Hypertrophy and atrophy inversely regulate Caveolin-3 expression in myoblasts

Biochemical and Biophysical Research Communications

Volumn 357, Issue 1, 2007, Pages 314-318

  Fanzani, Alessandro ^a   Musarò, Antonio ^b   Stoppani, Elena ^a   Giuliani, Roberta ^a   Colombo, Francesca ^a   Preti, Augusto ^a   Marchesini, Sergio ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

AKT; Atrophy; Caveolin 3; Dexamethasone; Hypertrophy; Igf 1; Starvation; Vasopressin

Indexed keywords

ARGIPRESSIN; CAVEOLIN 3; MAMMALIAN TARGET OF RAPAMYCIN; MITOGEN ACTIVATED PROTEIN KINASE P38;

ANIMAL CELL; ARTICLE; ATROPHY; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; GENETIC TRANSFECTION; HYPERTROPHY; MOUSE; MUSCLE DEVELOPMENT; MUSCLE HYPERTROPHY; MYOBLAST; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STARVATION; TRANSGENIC MOUSE; UPREGULATION;

ANIMALS; CAVEOLIN 3; CELL LINE; HYPERTROPHY; MICE; MUSCLE FIBERS; MUSCLE, SKELETAL; MUSCULAR ATROPHY; MYOBLASTS; STATISTICS;

MUS MUSCULUS;

EID: 34147128560     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.03.148     Document Type: Article

References (39)

1. Glenney J.R., and Soppet D. Sequence and expression of caveolin, a protein component of caveolae plasma membrane domains phosphorylated on tyrosine in RSV-transformed fibroblasts. Proc. Natl. Acad. Sci. USA 89 (1992) 10517-10521
2. Scherer P.E., Okamoto T., Chun M., Nishimoto I., Lodish H.F., and Lisanti M.P. Identification, sequence and expression of caveolin-2 defines a caveolin gene family. Proc. Natl. Acad. Sci. USA 93 (1996) 131-135
3. Tang Z.L., Scherer P.E., Okamoto T., Song K., Chu C., Kohtz D.S., Nishimoto I., Lodish H.F., and Lisanti M.P. Molecular cloning of caveolin-3, a novel member of the caveolin gene family expressed predominantly in muscle. J. Biol. Chem. 271 (1996) 2255-2261
4. Way M., and Parton R. M-caveolin, a muscle-specific caveolin-related protein. FEBS Lett. 376 (1995) 108-112
5. Lisanti M.P., Scherer P., Tang Z.L., and Sargiacomo M. Caveolae, caveolin, and caveolin-rich membrane domains: a signalling hypothesis. Trends Cell. Biol. 4 (1994) 231-235
6. Smart E.J., Graf G.A., McNiven M.A., Sessa W.C., Engelman J.A., Scherer P.E., Okamoto T., and Lisanti M.P. Caveolins, liquid-ordered domains, and signal transduction. Mol. Cell. Biol. 19 (1999) 7289-7304
7. Galbiati F., Razani B., and Lisanti M.P. Emerging themes in lipid rafts and caveolae. Cell 106 (2001) 403-411
8. Li S., Song K.S., and Lisanti M.P. Expression and characterization of recombinant caveolin. J. Biol. Chem. 271 (1996) 568-573
9. Murata M., Peranen J., Schreiner R., Weiland F., Kurzchalia T., and Simons K. VIP21/Caveolin is a cholesterol-binding protein. Proc. Natl. Acad. Sci. USA 92 (1995) 10339-10343
10. Fra A.M., Masserini M., Palestini P., Sonnino S., and Simons K. A photo-reactive derivative of ganglioside GM1 specifically cross-links VIP21-caveolin on the cell surface. FEBS Lett. 375 (1995) 11-14
11. Li S., Okamoto T., Chun M., Sargiacomo M., Casanova J.E., Hansen S.H., Nishimoto I., and Lisanti M.P. Evidence for a regulated interaction between heterotrimeric G proteins and caveolin. J. Biol. Chem. 270 (1995) 15693-15701
12. Song K.S., Li S., Okamoto T., Quilliam L., Sargiacomo M., and Lisanti M.P. Co-purification and direct interaction of Ras with caveolin, an integral membrane protein of caveolae microdomains. J. Biol. Chem. 271 (1996) 9690-9697
13. Li S., Couet J., and Lisanti M.P. Src tyrosine kinases, Ga subunits, and H-Ras share a common membrane-anchored scaffolding protein, caveolin. J. Biol. Chem. 271 (1996) 29182-29190
14. Shaul P.W., Smart E.J., Robinson L.J., German Z., Yuhanna I.S., Ying Y., Anderson R.G.W., and Michel T. Acylation targets endothelial nitric-oxide synthase to plasmalemmal caveolae. J. Biol. Chem. 271 (1996) 6518-6522
15. Garcia-Cardena G., Oh P., Liu J., Schnitzer J.E., and Sessa W.C. Targeting of nitric oxide synthase to endothelial cell caveolae via palmitoylation: Implications for nitric oxide signaling. Proc. Natl. Acad. Sci. USA 93 (1996) 6448-6453
16. Smythe G.M., Eby J.C., Disatnik M.H., and Rando T.A. A caveolin-3 mutant that causes limb girdle muscular dystrophy type 1C disrupts Src localization and activity and induces apoptosis in skeletal myotubes. J.Cell Sci. 116 (2003) 4739-4749
17. Sotgia F., Lee J.K., Das K., Bedford M., Petrucci T.C., Macioce P., Sargiacomo M., Bricarelli F.D., Minetti C., Sudol M., and Lisanti M.P. Caveolin-3 directly interacts with the C terminal tail of beta-dystroglycan. Identification of a central WW-like domain within caveolin family members. J. Biol. Chem. 275 (2000) 38048-38058
18. Song K.S., Scherer P.E., Tang Z., Okamoto T., Li S., Chafel M., Chu C., Kohtz D.S., and Lisanti M.P. Expression of caveolin-3 in skeletal, cardiac, and smooth muscle cells. Caveolin-3 is a component of the sarcolemma and co-fractionates with dystrophin and dystrophin-associated glycoproteins. J. Biol. Chem. 271 (1996) 15160-15165
19. Scherer P.E., and Lisanti M.P. Association of phosphofructokinase-M with caveolin-3 in differentiated skeletal myotubes. Dynamic regulation by extracellular glucose and intracellular metabolites. J. Biol. Chem. 272 (1997) 20698-20705
20. Matsuda C., Hayashi Y.K., Ogawa M., Aoki M., Murayama K., Nishino I., Nonaka I., Arahata K., and Brown Jr. R.H. The sarcolemmal proteins dysferlin and caveolin-3 interact in skeletal muscle. Hum. Mol. Genet. 10 (2001) 1761-1766
21. Scherer P.E., Lewis R.Y., Volonte D., Engelman J.A., Galbiati F., Couet J., Kohtz D.S., van Donselaar E., Peters P., and Lisanti M.P. Cell-type and tissue-specific expression of caveolin-2. Caveolins 1 and 2 co-localize and form a stable hetero-oligomeric complex in vivo. J. Biol. Chem. 272 (1997) 29337-29346
22. Galbiati F., Volonte D., Engelman J.A., Scherer P.E., and Lisanti M.P. Targeted down-regulation of caveolin-3 is sufficient to inhibit myotube formation in differentiating C2C12 myoblasts. Transient activation of p38 mitogen-activated protein kinase is required for induction of caveolin-3 expression and subsequent myotube formation. J. Biol. Chem. 274 (1999) 30315-30321
23. Minetti C., Sotgia F., Bruno C., Scartezzini P., Broda P., Bado M., Masetti E., Mazzocco P., Egeo A., Donati M.A., Volonté D., Galbiati F., Cordone G., Bricarelli F.D., Lisanti M.P., and Zara F. Mutations in the caveolin-3 gene cause autosomal dominant limb-girdle muscular dystrophy. Nat. Genet. 18 (1998) 365-368
24. Galbiati F., Volonte D., Minetti C., Bregman D.B., and Lisanti M.P. Limb-girdle muscular dystrophy (LGMD-1C) mutants of caveolin-3 undergo ubiquitination and proteasomal degradation. J. Biol. Chem. 275 (2000) 37702-37711
25. Galbiati F., Volonte D., Chu J.B., Li M., Fine S.W., Fu M., Bermudez J., Pedemonte M., Weidenheim K.M., Pestell R.G., Minetti C., and Lisanti M.P. Transgenic overexpression of caveolin-3 in skeletal muscle fibers induces a Duchenne-like muscular dystrophy phenotype. Proc. Natl. Acad. Sci. USA 97 (2000) 9689-9694
26. Musarò A., McCullagh K., Paul A., Houghton L., Dobrowolny G., Molinaro M., Barton E.R., Sweeney H.L., and Rosenthal N. Localized Igf-1 transgene expression sustains hypertrophy and regeneration in senescent skeletal muscle. Nat. Genet. 27 (2001) 195-200
27. Jiang B.H., Aoki M., Zheng J.Z., Li J., and Vogt P.K. Myogenic signaling of phosphatidylinositol 3-kinase requires the serine-threonine kinase Akt/protein kinase B. Proc. Natl. Acad. Sci. USA 96 (1999) 2077-2081
28. Pallafacchina G., Calabria E., Serrano A.L., Kalhovde J.M., and Schiaffino S. A protein kinase B-dependent and rapamycin-sensitive pathway controls skeletal muscle growth but not fiber type specification. Proc. Natl. Acad. Sci. USA 99 (2002) 9213-9218
29. Coleman M.E., DeMayo F., Yin K.C., Lee H.M., Geske R., Montgomery C., and Schwartz R.J. Myogenic vector expression of insulin-like growth factor I stimulates muscle cell differentiation and myofiber hypertrophy in transgenic mice. J. Biol. Chem. 270 (1995) 12109-12116
30. Lai K.M., Gonzalez M., Poueymirou W.T., Kline W.O., Na E., Zlotchenko E., Stitt T.N., Economides A.N., Yancopoulos G.D., and Glass D.J. Conditional activation of akt in adult skeletal muscle induces rapid hypertrophy. Mol. Cell. Biol. 24 (2004) 9295-9304
31. 2+/calmodulin dependent kinase and calcineurin pathways. Mol. Biol. Cell 16 (2005) 3632-3641
32. Nervi C., Benedetti L., Minasi A., Molinaro M., and Adamo S. Arginine-vasopressin induces differentiation of skeletal myogenic cells and up-regulation of myogenin and Myf-5. Cell. Growth Differ. 6 (1995) 81-89
33. Minotti S., Scicchitano B.M., Nervi C., Scarpa S., Lucarelli M., Molinaro M., and Adamo S. Vasopressin and insulin-like growth factors synergistically induce myogenesis in serum-free medium. Cell. Growth Differ. 9 (1998) 155-163
34. Scicchitano B.M., Spath L., Musaro A., Molinaro M.., Adamo S., and Nervi C. AVP induces myogenesis through the transcriptional activation of the myocyte enhancer factor 2. Mol. Endocrinol. 16 (2002) 1407-1416
35. Musaro A., and Rosenthal N. Maturation of the myogenic program is induced by postmitotic expression of insulin-like growth factor I. Mol. Cell. Biol. 19 (1999) 3115-3124
36. Musaro A., McCullagh K.J., Naya F.J., Olson E.N., and Rosenthal N. IGF-1 induces skeletal myocyte hypertrophy through calcineurin in association with GATA-2 and NF-ATc1. Nature 400 (1999) 581-585
37. Grieshammer U., Sassoon D., and Rosenthal N. A transgene target for positional regulators marks early rostrocaudal specification of myogenic lineages. Cell 69 (1992) 79-93
38. Mitch W.E., and Goldberg A.L. Mechanisms of muscle wasting. The role of the ubiquitin-proteasome pathway. N. Engl. J. Med. 335 (1996) 1897-1905 Review
39. Lecker S.H., Solomon V., Mitch W.E., and Goldberg A.L. Muscle protein breakdown and the critical role of the ubiquitin-proteasome pathway in normal and disease states. J. Nutr. 129 (1999) 227S-237S Review